Navigation Links
Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia,Clinical Trial

of cethromycin in CAP patients compared to Biaxin(R). Trial CL-06 enrolled patients from clinics in Europe, South America and Israel and Trial CL-05 has enrolled patients from North America and South Africa. Cethromycin was evaluated using a 300 mg once-daily dosing regimen compared to 250 mg twice-daily dosing for Biaxin(R), both over a seven-day course of therapy. Biaxin(R) is an FDA-approved macrolide antibiotic currently indicated for the treatment of CAP.

The primary endpoint for both trials is the clinical cure rate at the test-of-cure visit (Day 14-21 post-initiation of dosing). The eligibility of patients for each trial was based on clinical signs and symptoms and chest X-ray as evaluated by an independent radiologist. Extensive electrocardiogram and liver function test monitoring were incorporated into the study design to examine safety in these areas, and to build on the safety database established in previous cethromycin clinical trials.

Each trial was powered to demonstrate non-inferiority at the 95% confidence interval. To achieve non-inferiority a drug must show that it does not statistically perform any worse than the comparator treatment.

About Community Acquired Pneumonia (CAP)

CAP is the sixth most common cause of death in the United States. CAP and other respiratory tract infections are caused by pathogens such as Streptococcus pneumoniae and Haemophilus influenzae. CAP affects 5-6 million patients in the United States each year, with 10 million physician visits and 2 million hospitalizations occurring annually.

Macrolides and penicillins are currently the first-line treatments for respiratory tract infections such as CAP. As macrolide and penicillin resistance grows and has the potential to cause more clinical failures, there is a need for new antibiotics with unique mechanisms of action, which can overcome this emerging resistance.

About Cethromycin

Cethromycin has shown higher in vitro potency a
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
2. Cethromycin Shown Effective Against Anthrax in Study
3. Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure Reduction During Important Early Morning Period When Most Adverse Cardiovascular Events Occur
4. Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL)
5. Micromet Achieves Milestone in BiTE Research Collaboration with MedImmune
6. Addex Achieves Statistically Significant Outcome in Phase IIa Clinical Trial With ADX10059 in Gastro-Esophageal Reflux Disease
7. Vicals Vaxfectin Adjuvant Achieves Dose-Sparing Effect With Seasonal Influenza Vaccine
8. Mymetics HIV Vaccine Achieves Research Breakthrough, Eliciting Protective Antibody Response in Mucosal Tissues of Non-Human Primate Model
9. Integrated Biopharmas Proprietary Vaccine Technology Achieves Strong Positive Results
10. Integrated BioPharmas Proprietary Vaccine Technology Achieves Strong Positive Results
11. ENDEAVOR IV Clinical Trial Meets Primary Endpoint
Post Your Comments:
(Date:10/17/2014)... , Oct. 17, 2014 With the ... Affairs function has come across several challenges in ... and managing globalization.  The ... is dedicated to providing benchmarking and best practices ... Consortium is a service composed of three stages: ...
(Date:10/17/2014)... 2014  Hanger, Inc. (NYSE: HGR ) ... of operations for the quarter ended September 30, 2014, ... A conference call to discuss these results is scheduled ... 7, 2014. Those wishing to participate should call 1-877-662-6095. ... 2014 by dialing 1-855-859-2056 and referencing Conference ID # ...
(Date:10/17/2014)... 2014 UBM Medica US announces that ... and information resource for neurologists and other healthcare providers, features ... disease , with discussions of the latest developments in approaches ... have Parkinson disease , more than the total of those ... disease. Diagnosis can be difficult because there are no ...
Breaking Medicine Technology:Early Key Findings from the Medical Affairs Consortium Research 2Neurology Times Features Coverage of Parkinson and Alzheimer Disease 2Neurology Times Features Coverage of Parkinson and Alzheimer Disease 3
... Business Council is pleased to announce that General Electric (GE), ... joint ventures in Russia. These joint ventures bolster GE,s position ... power generation and healthcare sectors. Under the ... billion in sales, GE will sell at least 77 gas ...
... NEW YORK, Sept. 16, 2011 Choosing ... be a confusing process.  Referrals from peers and subsequent ... experience and results.  Patients need to be educated on ... go in search of a plastic surgeon for treatment. ...
Cached Medicine Technology:USRBC President Ed Verona Lauds GE Announcement on Energy and Healthcare Joint Ventures in Russia 2Trust Your Derm: The JUVA Skin & Laser Center Advises Patients To Seek Board Certified Dermatologists and AAAHC Accredited Facilities For Safe Cosmetic Procedures 2
(Date:10/20/2014)... Angeles, CA (PRWEB) October 20, 2014 ... fitness expertise, nutritional coaching, corporate wellness programming, authorship, international ... CPT, is excited to announce the release of the ... , After many years of coaching thousands of individuals ... nutrition tracking app that does not require calorie counting ...
(Date:10/20/2014)... 2014 Rockynol Retirement Community ... Oct. 14. The $11 million project will include the ... cooked-to-order kitchen with full-service restaurant style dining. , “We ... first class Assisted Living apartments,” said Kara Hanzie, Rockynol ... highest quality of care and this investment is proof ...
(Date:10/20/2014)... Unveiled at the Sept. 18 board meeting, The ... member hospital ROI on membership dues at 12.5. In other ... $12.50 in value to member hospitals. The calculation used to ... Dues. , “This is the first time we’ve actually ... the methodology is really sound,” said Bill Ryan , ...
(Date:10/19/2014)... Hastings and Hastings, a Phoenix personal injury law firm ... Phoenix area and across Arizona reports record demand in ... accidents. Statistics have indicated a steady increase in automobile ... Hastings and Hastings has seen a steady increase in ... been injured through no fault of their own that ...
(Date:10/19/2014)... October 20, 2014 Having been working in ... good knowledge of customer needs. According to James, one of ... with dazzling sequins, or with high-low skirts that add beauty ... huge demand. Recently, LunaDress has unveiled its new selection of ... fact, the company’s brand new items are available in over ...
Breaking Medicine News(10 mins):Health News:JZ Fitness Nutrition App Launches on iTunes 2Health News:JZ Fitness Nutrition App Launches on iTunes 3Health News:Rockynol Retirement Community Expands Assisted Living Center 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 4Health News:Hastings And Hastings Reports Record Demand In 2014 For Legal Representation With Regard To Catastrophic Automobile Accidents 2Health News:Hastings And Hastings Reports Record Demand In 2014 For Legal Representation With Regard To Catastrophic Automobile Accidents 3Health News:2014 Long Prom Dresses From LunaDress Now Available In Over 20 Popular Designs 2
... , , WEST PALM BEACH, ... leading providers of he a ring aids ... a hearing care program designed exclusively for AARP members. The program is scheduled ... October and will eventually be extended to AARP members in all 50 states ...
... , Dr. Mubin Syed evaluates findings; ... Ohio, Aug. 11 A new study by Mayo Clinic researchers ... of vertebroplasty to treat osteoporotic spinal fractures. , , ... is injected into vertebrae to relieve pain and improve mobility in ...
... , , Survey seeks feedback from ... , , CHICAGO, Aug. 11 Participate in the American ... and become eligible to win a $150 Amazon.com gift certificate ... , ADA.org provides news and information on hundreds of dental ...
... , , FRAMINGHAM, Mass. and SYDNEY, Aug. ... today announced that it is scheduled to make an investor presentation at ... on Thursday, August 13, 2009. The conference will be held at the ... live webcast of the Company,s presentation at the conference will be available ...
... , , LAKEWOOD, Colo., Aug. 11 ... that its Board of Directors has declared a regular quarterly cash ... September 15, 2009 to shareholders of record at the close of ... Laboratories develops, acquires, manufactures and markets electronic instruments and disposables for ...
... , CLEVELAND, Aug. 11 Herbruck ... convene six medical insurance companies on Thursday, August 20 ... impact of pending federal healthcare legislation on employers. ... important because Americans across the country are discussing and ...
Cached Medicine News:Health News:HearUSA Makes Hearing Aids and Care Available to AARP Members 2Health News:HearUSA Makes Hearing Aids and Care Available to AARP Members 3Health News:HearUSA Makes Hearing Aids and Care Available to AARP Members 4Health News:Noted Vertebroplasty Expert Cites Concerns About Recently Published Study 2Health News:American Dental Association Web Survey Offers Chance at $150 Gift Certificate 2
Chin Implants are used for cosmetic augmentation, repairing trauma related injuries and genetic deficiencies. They are inserted through an incision in the mouth below the incisor teeth or through an ...
... The IEC CL40 and FL40 ... power, safety and versatility to increase ... with a broad array of rotors ... processing and microplate applications, the IEC ...
... The IEC CL30 Series from ... exceptional value for your low-speed ... AUTO-LOCK rotor exchange system, user-friendly ... the IEC CL30 Series delivers ...
Chembio Diagnostic Systems, Inc.s SURE CHECK HIV 1 / 2, HIV 1/ 2 STAT-PAK and HIV 1/ 2 STAT-PAK Dipstick tests are easy-to-perform, single-use diagnostic tests for the rapid, visual detection of anti...
Medicine Products: